Telofinsit 40/5/12.5 mg (Telmisartan, Amlodipine Besylate, Chlorthalidone)

Adult dose

This medication is taken once daily, 1 tablet with water, regardless of meals. It is recommended to take it at the same time every day (e.g., in the morning). Telmisartan/Amlodipine combination therapy can be administered for patients whose blood pressure is not controlled, with 40/5/12.5 mg; dosing can be adjusted every two weeks based on the patient's blood pressure response. The maximum recommended dosage for this medication is 80/5/25.

This medication should not be used during pregnancy, especially in the second and third trimesters, as it can cause serious harm to the fetus. Patients with impaired liver function or progressive liver disease should be cautious, as serious issues like hepatic coma may occur while taking this medication. Patients with severe renal disease may experience hyperazotemia due to the diuretic component, so kidney function should be closely monitored. This medication should not be administered to individuals with allergies to this drug or its components, pregnant or breastfeeding women, patients with severe liver dysfunction, severe aortic stenosis, or in shock. In particular, patients with diabetes or moderate to severe kidney impairment should avoid concurrent use of this medication with specific drugs, and those with hypokalemia, hyponatremia, or hypercalcemia should exercise caution. Patients with primary aldosteronism, heart valve diseases, liver disorders, gastrointestinal diseases, or renal vascular hypertension should use this medication carefully, and the elderly should start at a low dose and be monitored. This medication may cause various side effects, such as dizziness, hypotension, headache, abdominal pain, and rashes, so any unusual symptoms experienced while taking the medication should be immediately discussed with healthcare professionals. Patients should regularly check their blood pressure, kidney function, and electrolyte levels during treatment to identify any abnormalities. Additionally, since this medication can interact with other drugs, patients should ensure they inform their healthcare provider of any other medications they are taking. Caution is advised as dizziness or drowsiness may occur when driving or operating machinery. In the event of overdose, symptoms such as hypotension, dizziness, or renal failure may develop, necessitating immediate medical attention. This medication has not been established as safe and effective for children, so it is advisable not to administer it to them. While storing this medication, keep it in a cool, dry place out of the reach of children, and avoid direct sunlight.

Serious side effects

Urticaria, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with fever, blisters, skin peeling, pain in mucous membranes of mouth/eyes, shortness of breath or difficulty breathing, asthma attacks, respiratory abnormalities accompanied by cough and fever, jaundice (yellowing of skin or eyes), extreme fatigue throughout the body, sudden and severe headache, thunderclap headache, seizure, cognitive confusion, visual disturbances, paralysis, urine

Mild side effects

• Dizziness
• dyslipidemia
• back pain
• rash
• orthostatic dizziness
• headache
• sensory disturbances
• abdominal pain
• rectal bleeding
• nausea

This medication is sensitive to light, so it should be stored in a container that protects it from light. It is also recommended to store it at room temperature between 1 to 30 degrees Celsius. Proper storage maintains the medication's efficacy and safety.

Appearance

White oval biconvex tablet

Package unit

30 tablets/box [10 tablets/PTP×3]